1stOncology™: Cancer Intelligence Service – Page 15488 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Pieris Pharmaceuticals to Host Full-Year 2017 Investor Call and Corporate Update on March 9, 2018

On February 28, 2018 Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other diseases, reported that it will host a full-year 2017 investor call on Friday, March 9, 2018 at 8:00 AM (EST) to discuss financial results and provide a corporate update (Press release, Pieris Pharmaceuticals, FEB 28, 2018, View Source [SID1234524247]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

To access the call, participants may dial 877-407-8920 (US & Canada) or 412-902-1010 (International) at least 10 minutes prior to the start of the call.

An archived replay of the call will be available for 30 days by dialing 877-660-6853 (US & Canada) or 201-612-7415 (International) and providing the Conference ID #: 13661472.

CTI BioPharma to Report Fourth Quarter and Full Year 2017 Financial Results on March 7, 2018

On February 28, 2018 CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) reported that management plans to report its fourth quarter and full year 2017 financial results on Wednesday, March 7, 2018, after the close of the U.S. financial markets (Press release, CTI BioPharma, FEB 28, 2018, View Source;p=RssLanding&cat=news&id=2335261 [SID1234524226]). Following the announcement, members of the management team will host a webcast conference call to discuss the results and provide a general corporate update at 4:30 p.m. ET (1:30 p.m. PT). Access to the event can be obtained as follows:

Wednesday, March 7, 2018
1:30 p.m. PT/4:30 p.m. ET/10:30 p.m. CET
1-800-289-0517 (domestic)
+1 323-994-2084 (international)

To access the live audio webcast or the subsequent archived recording, visit CTI BioPharma’s website, www.ctibiopharma.com. Webcast and telephone replays of the conference call will be available approximately two hours after completion of the call. Callers can access the replay by dialing 1-888-203-1112 (domestic) or +1 719-457-0820 (international). The access code for the replay is 2516357. The telephone replay will be available until Wednesday, March 14, 2018.

BioTime to Present at the Raymond James 39th Annual Institutional Investor Conference

On February 28, 2018 BioTime, Inc. (NYSE American: BTX), a late-stage, clinical biotechnology company developing and commercializing products addressing degenerative diseases, reported that Russell Skibsted, Chief Financial Officer of BioTime, will be presenting at the Raymond James 39th Annual Institutional Investor Conference on Wednesday, March 7, 2018 at 10:25am ET, at the J.W. Marriott Grande Lakes Hotel (Press release, BioTime, FEB 28, 2018, View Source;p=RssLanding&cat=news&id=2335255 [SID1234524223]).

Mr. Skibsted will also be meeting with investors throughout the conference. One-on-one meetings with Mr. Skibsted may be scheduled through the Raymond James 1×1 desk or by contacting David Nakasone, Director of Investor Relations at BioTime, at 510-871-4188 or [email protected].

About The Raymond James 39th Annual Institutional Investors Conference

The Institutional Investors Conference, held annually in Orlando, Florida during the first week of March, is Raymond James’ signature event. In 2017, the event featured over 300 companies and more than 900 institutional investors from the U.S., Canada and Europe.

Allergan to Present at The Barclays Global Healthcare Conference

On February 28, 2018 Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, reported that Chairman and CEO Brent Saunders will present at the Barclays Global Healthcare Conference in Miami, FL (Press release, Allergan, FEB 28, 2018, View Source(1) [SID1234524221]). The presentation will begin at 1:35 p.m. Eastern Time on Wednesday, March 14, 2018.

The presentation will be webcast live and can be accessed on Allergan’s Investor Relations website at www.allergan.com/investors. The webcast can also be accessed through the following URL: https://cc.talkpoint.com/barc0…

An archived version will be available within approximately 4 hours of the live presentation, and can be accessed at the same location for 180 days.

Aclaris Therapeutics to Webcast Conference Call Discussing Fourth Quarter and Full Year 2017 Financial Results on March 12, 2018

On February 28, 2018 Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology, reported that it will report financial results for the fourth quarter and year ending December 31, 2017 on Monday, March 12, 2018, before the U.S. financial markets open (Press release, Aclaris Therapeutics, FEB 28, 2018, https://aclaristherapeuticsinc.gcs-web.com/news-releases/news-release-details/aclaris-therapeutics-webcast-conference-call-discussing-fourth [SID1234524219]).

Management will provide an update on the Company and discuss fourth quarter and year-end 2017 results as well as expectations for the future via conference call on Monday, March 12, 2018, at 8:00 AM ET. To participate on the live call, please dial (844) 776-7782 (domestic) or (661) 378-9535 (international), and reference conference ID 1495576 prior to the start of the call.

A live webcast of the event can be accessed on the Events and Presentations page on the Investors section of the Aclaris website at View Source A replay of the webcast will be archived on the Aclaris website following the event.